Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Hepatic Cancers”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Not applicableUnknownNCT03731923
What this trial is testing

Abbreviated MRI for HCC Surveillance

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis
Seoul National University Hospital 257
Large-scale testing (Phase 3)Active Not RecruitingNCT04639180
What this trial is testing

Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 687
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Not applicableUnknownNCT04705194
What this trial is testing

Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging

Who this might be right for
HepatectomyLiver FailureLiver Cancer+1 more
University of Leeds 134
Large-scale testing (Phase 3)UnknownNCT05910970
What this trial is testing

Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation

Who this might be right for
Hepatocellular CarcinomaRecurrenceImmune Checkpoint Inhibitor
Guangxi Medical University 200
Not applicableUnknownNCT06134973
What this trial is testing

A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.

Who this might be right for
Hepatocellular Carcinoma
Tianjin Third Central Hospital 1,000
Not applicableNot Yet RecruitingNCT07010588
What this trial is testing

Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk

Who this might be right for
Hepatocellular Carcinoma (HCC)Magnetic Resonance Imaging (MRI)Randomized Controlled Trial
Peking University People's Hospital 1,389
Not applicableLooking for participantsNCT07291141
What this trial is testing

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

Who this might be right for
Liver CirrhosesHepatocellular Carcinoma (HCC)Sarcopenia in Liver Cirrhosis+3 more
Mattias Ekstedt 600
Not applicableUnknownNCT05546619
What this trial is testing

Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection

Who this might be right for
Hepatocellular Carcinoma
Sulai Liu 30
Not applicableEnrolling By InvitationNCT06647264
What this trial is testing

Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

Who this might be right for
Hepatocellular CarcinomasCholecystectomy, LaparoscopicHepatectomy+1 more
Nanfang Hospital, Southern Medical University 1,500
Not applicableStudy completedNCT03405909
What this trial is testing

Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma, IntrahepaticLiver Cirrhosis+3 more
University Hospital Erlangen 517
Not applicableUnknownNCT03687853
What this trial is testing

Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery

Who this might be right for
Pancreatic Ductal AdenocarcinomaWho Have High CTCs Count in Portal Venous BloodLiver Metastases
Peking University Third Hospital 80
Not applicableLooking for participantsNCT06577272
What this trial is testing

Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Tian'an Jiang 6,000
Not applicableStudy completedNCT07030842
What this trial is testing

Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tongji Hospital 579
Testing effectiveness (Phase 2)UnknownNCT05213637
What this trial is testing

Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma (HCC)
Chinese PLA General Hospital 430
Not applicableStudy completedNCT01446666
What this trial is testing

Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients

Who this might be right for
Cirrhosis of Liver
Asan Medical Center 423
Testing effectiveness (Phase 2)Study completedNCT02447679
What this trial is testing

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Who this might be right for
Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaAdverse Reaction to Drug+1 more
Chang Gung Memorial Hospital 40
Not applicableStudy completedNCT04722120
What this trial is testing

Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 68
Load More Results